Monoclonal antibodies (MAbs) against Rickettsia tsutsugamushi Kawasaki were prepared. The crossreactivity tests of the MAbs performed by using antigenically distinct strains of R. tsutsugamushi in immunofluorescence and immunoblotting analyses indicated that the Kawasaki strain contains a strain-specific epitope and also contains a common epitope on the 56-kDa polypeptide cross-reactive with the Gilliam strain, group-and subgroup-specific epitopes on the 46-kDa polypeptide, and a subgroup-specific epitope on the 25-kDa polypeptide. By using the strain-specific MAb for serodiagnosis of tsutsugamushi disease (or scrub typhus fever), we have established a method which was designated the inhibition enzyme-linked immunosorbent assay. The principle of the method is to measure the percentage of inhibition of antigen adsorption on a MAb-coated plate by antibody-positive sample sera which were mixed with the antigen suspension. The advantages of this test for practical use are that (i) crude antigen can be used, i.e., purification of the antigen is not required; (ii) the test is more sensitive than immunofluorescence; (iii) the final judgment of plus or minus is clear-cut; and (iv) rickettsial antigenic types in the patients can be distinguished by this test.
Rickettsia tsutsugamushi, the causative agent of tsutsugamushi disease, or scrub typhus fever, is unique among the Rickettsia spp. because of the presence of various antigenic variants. The antigenic types of three prototype strains, Gilliam, Karp, and Kato, are well known. Our recent works have demonstrated the presence of other antigenic types such as Shimokoshi, Kawasaki, and Kuroki strains which are distinguishable not only from the prototype strains but also from one another (9, 13, 14) . Furthermore, localized distributions of these antigenic types were observed (6, 13) . For example, all R. tsutsugamushi isolates from patients in Miyazaki prefecture were Kawasaki and Kuroki types, while the majority of isolates from Niigata prefecture are Gilliam and Karp types. These recent findings have been made possible by the progress of methods for antigenic analysis of rickettsiae, especially by the use of various kinds of antirickettsial monoclonal antibodies (MAbs) (6, 8, 14) . Although recent serodiagnoses of tsutsugamushi disease have been performed mainly by the methods of immunofluorescence assay (IF) or immunoperoxidase treatment, the development of other simple, convenient, and accurate methods is still being investigated (11) .
In the present study, a modified enzyme-linked immunosorbent assay (ELISA) was developed and applied for serodiagnosis of tsutsugamushi disease by using strain-specific MAbs against the Kawasaki strain which we had prepared. The method is as follows. Wells of an ELISA microplate are coated with Kawasaki strain-specific MAb. Then, crude rickettsial antigen (Kawasaki strain antigen) which was mixed with a test serum is adsorbed to the wells, and the percentage of inhibition of the antigen adsorption by the test serum is measured by ELISA using a peroxidase-conjugated Kawasaki strain-specific MAb. We designated this method the inhibition ELISA. In the first part of the present paper, we describe the preparation and characterization of MAbs against the Kawasaki strain, and in the second part we describe the usefulness of the inhibition ELISA for serodiagnosis of rickettsial infection by R. tsutsugamushi Ka- wasaki, especially in the acute phase of infection.
MATERIALS AND METHODS
Rickettsial strains. R. tsutsugamushi Gilliam, Karp, Kato, Shimokoshi, Kawasaki, and Kuroki were used. The first three strains are laboratory strains which have been commonly used as prototypes. The last three were isolated from patients in Niigata and Miyazaki prefectures, and partial characterization of their properties was reported previously (9, 13, 14) . All of these strains were propagated in cultures of GMK cells, Vero cells (both originated from green monkey kidney), or L cells (mouse fibroblasts). The detailed procedures for cultivation and propagation were the same as those described previously (13, 14) .
Preparation of MAbs. The details were essentially the same as those described previously (2) . Briefly, a suspension of Kawasaki strain antigen prepared from the infected GMK cell cultures was emulsified in Freund's complete adjuvant, and the emulsion was injected intraperitoneally into BALB/c mice. After 2 months, the mice were boosted once intravenously by injecting the same antigen; on day 3 after the booster injection, the spleen cells were fused with mouse myeloma P3X63Ag8U1 cells (4) 10 ' M hypoxanthine, 4 x 10-7 M aminopterin, and 1.6 x 10-5 M thymidine) and screened for reactivity with Kawasaki antigen by ELISA, and positive hybridomas were cloned by single-cell manipulation and cultivated on a feeder layer of mouse thymus cells. Then, 107 hybridoma cells were injected intraperitoneally into BALB/c mice which had received prior injection with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane), and the ascitic fluids were collected on days 10 to 14. The ascitic fluids were centrifuged at 6,600 x g for 20 min, and supernatants were partially purified by chromatography by using a Sephacryl S-300 column (Pharmacia Fine Chemicals, Uppsala, Sweden) and used as MAb preparations. Immunoglobulin classes and subclasses of the MAbs were determined by double immunodiffusion tests by using anti-mouse immunoglobulin Gl (IgGl), IgG2a, IgG2b, IgG3, IgM, and IgA antibodies prepared in rabbits (Miles Laboratories, Elkhart, Ind.).
IF. Indirect IF was performed as described previously (6, 14) . The secondary antibodies used were fluorescein isothiocyanate-conjugated goat IgGs against (i) mouse IgM (>-chain specific), (ii) the Fc fragment of mouse IgG (y-chain specific), (iii) human IgM (,u-chain specific), and (iv) the Fc fragment of human IgG (-y-chain specific), all purchased from Tago, Inc. (Burlingame, Calif.).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. The detailed procedures for SDS-PAGE and immunoblotting were essentially the same as those described previously (8) . The resolving gel contained 10% polyacrylamide. The rickettsiae were purified by Percoll (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) density gradient centrifugation (10) and solubilized in sample buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 5 mM EDTA, 0.001% bromophenol blue, 0.065 M Tris hydrochloride buffer, pH 6.8) at 100°C for 10 min. After electrophoresis, the gel was stained with Coomassie brilliant blue. The secondary antibody used for immunoblotting was horseradish peroxidase-conjugated anti-mouse IgG (heavyand light-chain specific) antibody prepared in rabbits (Cappel Laboratories, Cochranville, Pa.).
Inhibition ELISA. (i) Preparation of peroxidase-labeled MAb. A Kawasaki strain-specific MAb (no. 358) was labeled with horseradish peroxidase type VI (Sigma, St. Louis, Mo.) by the method of Yamada et al. (12) . Prior to use, the peroxidase-labeled MAb was diluted to a concentration of 8 ,ug of protein per ml in phosphate-buffered saline (PBS) containing 0.05% Tween 20 and 0.1% bovine serum albumin (PBSTB).
(ii) Preparation of rickettsial antigen. Infected cells in a monolayer in a 500-ml culture bottle were scratched off by gently shaking with 8-g glass beads (3-mm diameter) into a small amount of culture medium. This suspension, which contained partially disrupted cells, was used as the antigen for the test without further purification. An appropriate concentration of the antigen for the test was determined in a preliminary test as described below.
( In immunoblotting analyses using these MAbs ( Fig. 1 and In the inhibition ELISA, MAbs 417 (group 1) and 3 (group 2) showed clear inhibition depending upon the antibody concentrations (Fig. 2) . The other MAbs in groups 1 and 2 also showed similar inhibition profiles. This result indicates that the MAbs in groups 1 and 2 may recognize the same epitope or a closely associated epitope(s) that is recognized by the MAb (no. 417) used for coating the wells. On the other hand, the MAbs in groups 3 to 5 did not show inhibition (although only MAbs 153, 11, and 52 are shown in other MAbs in groups 3 to 5 did not show inhibitory properties either), indicating that the MAbs in groups 3 to 5 did not compete with the MAb (no. 417) used for coating. Inhibition ELISAs were performed by using patients' sera, and the results were compared with those of IF titrations ( Table 2 ). The patients' sera that were strongly reactive with the Kawasaki strain in IF showed clear positive results in the inhibition ELISA. Furthermore, sera from patients in the acute phase of tsutsugamushi disease, in which the IF titers were still low, appeared to be positive by the inhibition ELISA. The patients' sera that were weakly reactive with the Kawasaki strain but strongly reactive with other strains in IFs, such as the sera of the patients 2 and 4, showed negative or plus-minus reaction in the inhibition ELISAs. The patients' sera reactive with none of the strains in IF (from patients 5 and 8) were also negative in inhibition ELISAs. Taken together, these results indicate that (i) if the patients are infected with R. tsutsugamushi Kawasaki or with closely related strains, the inhibition ELISA will show clear positive results and (ii) this method is useful to estimate the serotype of rickettsiae which infected the patients, especially in the acute phase of tsutsugamushi disease. 
DISCUSSION
The presence of strain-or type-specific epitopes on the 54-to 56-kDa polypeptides located on the surface of R. tsutsugamushi was first reported by us (8) , and this was confirmed by immunoblotting analyses using strain-specific MAbs (1, 3, 6) . In our previous study, the Kawasaki strain was defined as a new antigenic type of R. tsutsugamushi distinguishable from the prototype strains Gilliam, Karp, and Kato by antigenic analyses using polyclonal and monoclonal antibodies (14) . However, we recognized in the previous study some degree of cross-reactivity between the 54-to 56-kDa polypeptides of the Kawasaki and of the Gilliam strains in immunoblotting analysis using guinea pig hyperimmune sera. These observations are supported by the present study, in which two kinds of MAbs were obtained: one is specific to the 54-to 56-kDa polypeptide of the Kawasaki strain and the other is cross-reactive with the 54-to 56-kDa polypeptides of both Kawasaki and Gilliam strains, suggesting that the 54-to 56-kDa polypeptide of the Kawasaki strain contains both antigenic sites.
The 46-to 47-kDa and 21-to 25-kDa polypeptides are also located on the rickettsial surface (8) . The 46-to 47-kDa polypeptide was first recognized as a common antigen among rickettsial strains in immunoblotting analyses using polyclonal antibodies (8) . However, some polyclonal antisera and patients' sera occasionally showed different intensities of reactivity with the 46-to 47-kDa polypeptides of each strain (7, 8, 14) . The fact that two kinds of MAbs against the 46-to 47-kDa polypeptide were obtained in the present study may correspond to these previous observations and suggests that the 46-to 47-kDa polypeptide may contain both common and subgroup-specific antigenic sites. The 21-to 25-kDa polypeptide could not be detected in immunoblotting analysis using guinea pig hyperimmune sera (8) 
